Oxford BioDynamics Plc (AIM:OBD)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.1100
+0.0075 (7.32%)
Nov 5, 2026, 4:35 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 14.79 million as of November 5, 2026. It is the 37,510th most valuable company in the world and the 814th biggest in the United Kingdom. Its market cap has increased by 136.02% in one year.
Market Cap
14.79M
Enterprise Value
16.55M
Revenue
1.20M
Global Rank
Country Rank
#814 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 14.79M, a decrease of -89.20%. That is a compound annual growth rate of -20.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 14.79M | 60.26% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 24.54M |
| ImmuPharma | 20.35M |
| SkinBioTherapeutics | 13.02M |
| Genflow Biosciences | 10.31M |
| Thalia Therapeutics | 9.78M |
| Aptamer Group | 9.37M |
| Palatin Technologies | 7.26M |
| Fusion Antibodies | 7.26M |